miércoles, 30 de septiembre de 2020

The Amyloidosis Forum: a public private partnership to advance drug development in AL amyloidosis | Orphanet Journal of Rare Diseases | Full Text

The Amyloidosis Forum: a public private partnership to advance drug development in AL amyloidosis | Orphanet Journal of Rare Diseases | Full Text

Immunoglobulin light chain (AL) amyloidosis is a rare, multi-systemic disorder characterized by two disease processes: an underlying plasma cell dyscrasia that provides the source of pathologic light chains, a...
Authors:Isabelle Lousada
Citation:Orphanet Journal of Rare Diseases 2020 15:268
Content type:Review
 
Published on: 

No hay comentarios:

Publicar un comentario